Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-45138
FASEB J 2012 Feb 01;262:513-22. doi: 10.1096/fj.11-189126.
Show Gene links Show Anatomy links

Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome.

Seebohm G , Strutz-Seebohm N , Ursu ON , Preisig-Müller R , Zuzarte M , Hill EV , Kienitz MC , Bendahhou S , Fauler M , Tapken D , Decher N , Collins A , Jurkat-Rott K , Steinmeyer K , Lehmann-Horn F , Daut J , Tavaré JM , Pott L , Bloch W , Lang F .


???displayArticle.abstract???
Inward rectifier potassium channels of the Kir2 subfamily are important determinants of the electrical activity of brain and muscle cells. Genetic mutations in Kir2.1 associate with Andersen-Tawil syndrome (ATS), a familial disorder leading to stress-triggered periodic paralysis and ventricular arrhythmia. To identify the molecular mechanisms of this stress trigger, we analyze Kir channel function and localization electrophysiologically and by time-resolved confocal microscopy. Furthermore, we employ a mathematical model of muscular membrane potential. We identify a novel corticoid signaling pathway that, when activated by glucocorticoids, leads to enrichment of Kir2 channels in the plasma membranes of mammalian cell lines and isolated cardiac and skeletal muscle cells. We further demonstrate that activation of this pathway can either partly restore (40% of cases) or further impair (20% of cases) the function of mutant ATS channels, depending on the particular Kir2.1 mutation. This means that glucocorticoid treatment might either alleviate or deteriorate symptoms of ATS depending on the patient's individual Kir2.1 genotype. Thus, our findings provide a possible explanation for the contradictory effects of glucocorticoid treatment on symptoms in patients with ATS and may open new pathways for the design of personalized medicines in ATS therapy.

???displayArticle.pubmedLink??? 22002906
???displayArticle.link??? FASEB J
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: col4a5